Dose–response association of acute-phase quetiapine treatment with risk of new-onset hypothyroidism in schizophrenia patients

11Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: To assess association between quetiapine treatment and risk of new-onset hypothyroidism in schizophrenia patients. Methods: We conducted a retrospective cohort study in a tertiary hospital in China between January 2016 and December 2018. Schizophrenia patients with normal thyroid tests at admission were included. Hypothyroidism, which was defined as thyroid-stimulating hormone >4.20 mU/L and free thyroxine <12.00 pmol/L, or on L-thyroxine prescriptions, was the outcome measure, and quetiapine treatment between admission and subsequent thyroid test was the exposure measure of this study. Adjusted relative risks and 95% confidence intervals were used to assess the independent association of quetiapine treatment with risk of new-onset hypothyroidism. The dose–response association was further analysed by 3 quetiapine doses: low (≤ 0.6 g/d). Results: A total of 2022 eligible patients were included in the final analysis. Sixty patients (15.0%) in the quetiapine group developed hypothyroidism, while 56 patients (3.5%) in the nonquetiapine group developed hypothyroidism. Relative risk (95% confidence interval) of developing hypothyroidism for quetiapine use was 4.01 (2.86–5.64) after adjusting for several potential confounding factors. A strong dose–response association between quetiapine use and risk of developing hypothyroidism was observed: adjusted relative risks (95% confidence intervals) were 1.00 (0.25–2.59), 4.22 (2.80–6.25) and 5.62 (3.66–8.38), respectively, for low-, medium- and high-dose quetiapine, as compared with no quetiapine. Conclusion: Acute phase quetiapine treatment for schizophrenia patients was strongly associated with increased risk of developing new-onset hypothyroidism, with a clear dose–response association.

Cite

CITATION STYLE

APA

Zhao, Y., Wen, S. W., Li, M., Sun, Z., Yuan, X., Retnakaran, R., … Zhai, D. (2021). Dose–response association of acute-phase quetiapine treatment with risk of new-onset hypothyroidism in schizophrenia patients. British Journal of Clinical Pharmacology, 87(12), 4823–4830. https://doi.org/10.1111/bcp.14928

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free